头颈癌诊断市场 - 全球行业规模、份额、趋势、机遇和预测，2017-2027 年：按类型、成像、活检、内窥镜、牙科诊断、最终用户、地区

在 2023 年至 2027 年的预测期内，全球头颈癌诊断市场预计将以惊人的复合年增长率增长。

人口老龄化加剧，容易患癌症等多种慢性病，这正在推动全球头颈癌诊断市场的增长。

癌症发病率上升推动市场增长

癌症是指细胞不受控制的异常生长，形成称为癌性或良性肿瘤的肿块。 特别是在工作人群中，久坐不动的生活方式会导致包括癌症在内的多种慢性疾病。 此外，越来越多的老年人由于免疫系统减弱而更容易患上慢性病，这进一步推动了全球头颈癌诊断市场的增长。 根据美国国家生物技术信息中心的一项研究，头颈癌是世界上第六大常见癌症。 经常吸烟和过度饮酒也被证明会增加消费者患头颈癌的风险。

对诊断成像设备不断增长的需求推动了市场增长

医学成像是指用于医学干预的身体内部可视化表示、器官和组织功能的可视化表示以及器官临床分析的技术和程序。 头颈癌是指一组起源于鳞状上皮的癌症，鳞状上皮通常分布在口腔、鼻子、颈部和喉咙。 头部MRI、鼻窦CT、头部CT、临床分析、全景牙科X光、牙科锥形束CT、PET/CT来检测这些癌症的精确位置并确定有无转移，以及胸部影像学是一些对患者进行的常见诊断程序。

对有效靶向治疗的需求不断增长推动市场增长

对于许多肿瘤学家来说，治疗头颈癌是一项艰鉅的任务。 治疗的可行性和选择取决于癌症的部位以及患者。 面部的复杂结构使头颈癌的手术治疗变得复杂，使手术成为医疗专业人员的首选治疗方式。 Oncosurgery 倾向于结合手术和放疗来治疗头颈癌。 准确诊断以分析癌症的严重程度对于手术后获得更好的结果起着重要作用。 基因疗法、抗体-药物偶联物和单克隆抗体等靶向分子疗法的引入为全球头颈癌诊断市场提供了潜在途径。

可自定义

TechSci Research 根据市场数据提供定制服务，以满足贵公司的独特需求。 该报告可以定制为：

公司信息

• 对其他市场公司（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章产品类型概述

第二章研究方法论

第 3 章 COVID-19 对全球头颈癌诊断市场的影响

第四章客户反馈

第 5 章执行摘要

第 6 章头颈癌诊断的全球市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（诊断成像、活检、内窥镜、牙科诊断剂）
  • 最终用户（医院、专科诊所、门诊手术中心、其他）
  • 按公司分类（2021 年）
  • 按地区
• 产品市场地图

第 7 章北美头颈癌诊断市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（诊断成像、活检、内窥镜、牙科诊断剂）
  • 最终用户（医院、专科诊所、门诊手术中心、其他）
  • 按国家
• 北美分析
  • 美国
  • 墨西哥
  • 加拿大

第 8 章：欧洲头颈癌诊断市场前景

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（诊断成像、活检、内窥镜、牙科诊断剂）
  • 最终用户（医院、专科诊所、门诊手术中心、其他）
  • 按国家
• 欧洲国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 9 章亚太地区头颈癌诊断市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（诊断成像、活检、内窥镜、牙科诊断剂）
  • 最终用户（医院、专科诊所、门诊手术中心、其他）
  • 按国家
• 亚太国家/地区分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 10 章南美头颈癌诊断市场前景

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（诊断成像、活检、内窥镜、牙科诊断剂）
  • 最终用户（医院、专科诊所、门诊手术中心、其他）
  • 按国家
• 南美分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第11章中东和非洲头颈癌诊断市场前景

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（诊断成像、活检、内窥镜、牙科诊断剂）
  • 最终用户（医院、专科诊所、门诊手术中心、其他）
  • 按国家
• MEA：国家分析
  • 南非的头颈癌诊断
  • 沙特阿拉伯的头颈癌诊断
  • 阿联酋的头颈癌诊断

第 12 章市场动态

• 司机
• 任务

第13章市场趋势与发展新兴国家市场趋势与发展

第14章竞争格局

• Addent Inc
• GE Healthcare
• Koninklijke Philips NV
• Shimadzu Corporation
• Siemens Healthineers AG
• Fujifilm Holdings Corporation
• Canon Medical system Corporation
• Carestream Healthcare Inc.
• Neusoft Medical Systems Co., Ltd.
• Varian Medical Systems, Inc.

第15章 策略建议

The global head and neck cancer diagnostic market is expected to grow at an impressive CAGR in the forecast period, 2023-2027. The increasing geriatric population who are more prone to numerous chronic diseases such as cancer is driving the growth of the global head and neck cancer diagnostic market.

Inflating disposable income leads to increased healthcare expenditure by the people. Furthermore, the escalating demand for diagnostic imaging, advancing treatment modes, and the incorporation of novel technologies in diagnostics equipment by the market players are expected to stimulate market growth. Also, the increased adoption of sedentary lifestyles and modifications in dietary habits is giving rise to several incidences among consumers, which further contributes to the global head and neck cancer diagnostics market growth. The growing need for targeted therapies and the awareness among the people regarding the availability and effectiveness of several oncological treatment procedures are expected to influence the global head and neck cancer diagnostic market growth in the forecast period.

Increasing Incidences of Cancer Propels the Market Growth

Cancer refers to the uncontrolled and abnormal growth of cells that form a mass known as a tumor that can be cancerous or benign. The adoption of sedentary lifestyles, especially among the working population, leads to various chronic illnesses, including cancer. The growing old age population who are more prone to any chronic diseases as their immune system gets weak further supports the growth of the global head and neck cancer diagnostics market. As per a study by the National Center for Biotechnology Information, head and neck cancer is considered the sixth-most common cancer globally. Regular consumption of tobacco and excessive alcohol consumption also increases the risk of head and neck cancer in consumers.

Rise In Demand for Diagnostic Imaging Equipment Fuels the Market Growth

Diagnostic imaging refers to the technique and procedure of creating visual representations of the interior of a body for medical intervention, visual representation of the function of some organs or tissues, and clinical analysis of any organ. Head and neck cancer refers to the group of cancers that generally begins in the squamous cells that line the mouth, nose, neck, and throat. To detect the accurate location of these kinds of cancer and determine if it has spread, head MRI, CT of the sinuses, head CT, clinical analysis and panoramic dental x-ray, dental cone beam CT, PET/CT, or chest imaging are a few of the common diagnostic procedures which are performed upon the patients.

Elevating Need for Effective Targeted Treatment Boosts the Market Growth

Treatment for head and neck cancer is a challenging task for many oncologists. Treatment availability and choice depend upon the location of cancer and vary from patient to patient. Due to the facial structure's complexity, the surgical treatments for head and neck cancers become complex, with surgery being the preferred mode of treatment mode among healthcare professionals. Onco-surgeon prefers surgical therapy in combination with radiation therapy for head and neck cancer treatment. For better results after surgery, accurate diagnosis plays a significant role in analyzing the cancer severity. The introduction of targeted molecular therapy, including gene therapy, antibody-drug conjugates, and monoclonal antibodies, offers a potential avenue for the global head and neck cancer diagnostics market.

Market Segmentation

The global head and neck cancer diagnostics market is segmented into type, end user, regional distribution, and competitive landscape. Based on the type, the market is divided into diagnostic imaging, biopsy, endoscopy, and dental diagnostics. Diagnostic imaging is further divided into PET/CT, MRI, X-Ray, and others and biopsy is divided into incisional biopsy, fine needle aspiration biopsy, and HPV testing. Similarly, endoscopy is divided into pharyngoscopy, laryngoscopy, and pan endoscopy, and dental diagnostics is divided into brush biopsy, fluorescence visualization, acetic acid rinse method, and toluidine blue dye-based met. Based on the end user, the market is divided into hospitals, specialty clinics, ambulatory surgical centers, and others. The market analysis also studies the regional segmentation, divided among the North American region, the Asia-Pacific region, the European region, the South American region, and the Middle East & African region.

Market Players

Addent Inc, GE Healthcare, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon Medical System Corporation, Carestream Healthcare Inc., Neusoft Medical Systems Co., Ltd., Varian Medical Systems, Inc. are the key market players leading the growth of the global head and neck cancer diagnostics market.

Report Scope

In this report, global head and neck cancer diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Head and Neck Cancer Diagnostics Market, By Type:

• Diagnostic Imaging
  • PET/CT
  • MRI
  • X-Ray
  • Others

• Biopsy
  • Incisional Biopsy
  • Fine Needle Aspiration Biopsy
  • HPV Testing

• Endoscopy
  • Pharyngoscopy
  • Laryngoscopy
  • Panendoscopy

• Dental Diagnostics
  • Brush Biopsy
  • Fluorescence Visualization
  • Acetic Acid Rinse Method
  • Toluidine Blue Dye-Based Method
  • Head and Neck Cancer Diagnostics Market, By End-User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

Head and Neck Cancer Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain

• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global head and neck cancer diagnostics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Type Overview

2. Research Methodology

3. Impact of COVID-19 on Global Head and Neck Cancer Diagnostics Market

4. Voice of Customer

5. Executive Summary

6. Global Head and Neck Cancer Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 6.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 6.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 6.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 6.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 6.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 6.2.3. By Company (2021)
  • 6.2.4. By Region
• 6.3. Product Market Map

7. North America Head and Neck Cancer Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 7.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 7.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 7.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 7.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 7.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Head and Neck Cancer Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Mexico Head and Neck Cancer Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Canada Head and Neck Cancer Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User

8. Europe Head and Neck Cancer Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 8.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 8.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 8.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 8.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 8.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 8.2.3. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Germany Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. United Kingdom Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. Italy Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Spain Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. Asia-Pacific Head and Neck Cancer Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 9.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 9.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 9.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 9.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 9.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 9.2.3. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. India Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Japan Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User
  • 9.3.4. South Korea Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By End User
  • 9.3.5. Australia Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Type
      • 9.3.5.2.2. By End User

10. South America Head and Neck Cancer Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 10.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 10.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 10.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 10.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 10.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Head and Neck Cancer Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Argentina Head and Neck Cancer Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. Colombia Head and Neck Cancer Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Middle East and Africa Head and Neck Cancer Diagnostics Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 11.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 11.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 11.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 11.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 11.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 11.2.3. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Head and Neck Cancer Diagnostics Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Type
      • 11.3.1.2.2. By End User
  • 11.3.2. Saudi Arabia Head and Neck Cancer Diagnostics Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Type
      • 11.3.2.2.2. By End User
  • 11.3.3. UAE Head and Neck Cancer Diagnostics Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Type
      • 11.3.3.2.2. By End User

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

• 14.1. Addent Inc
• 14.2. GE Healthcare
• 14.3. Koninklijke Philips NV
• 14.4. Shimadzu Corporation
• 14.5. Siemens Healthineers AG
• 14.6. Fujifilm Holdings Corporation
• 14.7. Canon Medical system Corporation
• 14.8. Carestream Healthcare Inc.
• 14.9. Neusoft Medical Systems Co., Ltd.
• 14.10. Varian Medical Systems, Inc.

15. Strategic Recommendations